Advertisement

Synthese

pp 1–24 | Cite as

An ethical obligation to ignore the unreliable

  • Bennett HolmanEmail author
S.I. : Reliability
  • 28 Downloads

Abstract

Stephen John has recently suggested that the ethics of communication yields important insights as to how values should be incorporated into science. In particular, he examines cases of “wishful speaking” in which a scientific actor (e.g. a tobacco company) endorses unreliable conclusions in order to obtain the consequences of the listener treating the results as credible. He concludes that what is wrong in these cases is that the speaker surreptitiously relies on values not accepted by the hearer, violating what he terms “the value-apt ideal”. I expand on this view by integrating into it Miranda Fricker’s account of testimonial injustice. I find testimonial injustice can arise in a manner unanticipated by Fricker, specifically that a credibility excess given to a speaker typically reduces the ability of others in the epistemic community to transmit knowledge, a phenomenon I term “collateral epistemic injustice”. I argue that this possibility entails that receivers have an ethical obligation to assign credibility judiciously. A further consequence of this view is that the value-apt ideal is insufficient. Because audience members have an obligation to assign credibility judiciously, a speaker cannot merely rely on shared values, they must also be open about the extent to which their conclusions depend on those values. Thus, both wishful speaking and obscuring the value-dependent nature of a conclusion makes one an unreliable source of information. Accordingly, other community members have an ethical obligation to ignore a speaker that frequently engages in either.

Keywords

Values in science Wishful speaking Epistemic injustice Industry-funded science Intransigently biased agents 

Notes

Acknowledgements

I would like to thank Steven John, Christopher ChoGlueck, and Kevin Elliott who all responded to questions and corrected (at least some of) the misunderstandings I had of their work. The form and substance of the paper was helped tremendously by insightful feedback from Elizabeth Seger, audiences at “Understanding Epistemic Injustice” conference, The University of Texas (El Paso), The University of Ghent, and two blind reviewers. Finally, I owe my biggest debt of gratitude to Justin Bruner. Not only was he kind enough to supply the graphs and to run the simulations reported in Sect. 3, the core of this paper emerges from our early work on intransigently biased agents. Sections 35 were revised and sharpened over multiple drafts and innumerable long conversations with him. Justin spotted numerous gaps in my thinking and though we do not agree on all points contained herein, the paper has been greatly improved by our ongoing disagreement.

References

  1. Anderson, E. (2012). Epistemic justice as a virtue of social institutions. Social Epistemology,26(2), 163–173.CrossRefGoogle Scholar
  2. Apfel, R. J., Fisher, S. M., & Fisher, S. (1986). To do no harm: DES and the dilemmas of modern medicine. New Haven: Yale University Press.Google Scholar
  3. Biddle, J., & Winsberg, E. (2010). Value judgements and the estimation of uncertainty in climate modeling. In P. D. Magnus & J. Busch (Eds.), New waves in philosophy of science (pp. 172–197). New York: Palgrave-Macmillan.CrossRefGoogle Scholar
  4. Buete, A. (2019). Psychiatric classification and epistemic injustice. Philosophy of Science.  https://doi.org/10.1086/705443.CrossRefGoogle Scholar
  5. Camp, E. (2013). Slurring perspectives. Analytic Philosophy,54, 330–349.CrossRefGoogle Scholar
  6. Caplow, T. (1952). Market attitudes: A research report from the medical field. Harvard Business Review,30(6), 105–112.Google Scholar
  7. CDC. (2012). Center for disease control and prevention. DES Update: Consumers. http://www.cdc.gov/des/consumers/index.html.
  8. ChoGlueck, C. (2019). Broadening the scope of our understanding of mechanisms: Lessons from the history of the morning-after pill. Synthese.  https://doi.org/10.1007/s11229-019-02201-0.CrossRefGoogle Scholar
  9. Coady, C. A. (1992). Testimony: A philosophical study. Oxford: Clarendon Press.Google Scholar
  10. CPC. (1939). Stilbestrol: Preliminary report of the council. Journal of the American Medical Association,113, 2312.Google Scholar
  11. Craig, E. (1991). Knowledge and the state of nature: An essay in conceptual synthesis. Oxford: Clarendon Press.Google Scholar
  12. Davis, E. (2016). Typecasts, tokens, and spokespersons: A case for credibility excess as testimonial injustice. Hypatia,31(3), 485–501.CrossRefGoogle Scholar
  13. Davis, M. E., & Fugo, N. W. (1950). Steroids in the treatment of early pregnancy complications. Journal of the American Medical Association,142(11), 778–785.CrossRefGoogle Scholar
  14. Dieckmann, W. J., Davis, M. E., Rynkiewicz, L. M., & Pottinger, R. E. (1953). Does the administration of diethylstilbestrol during pregnancy have therapeutic value? American Journal of Obstetrics and Gynecology,66(5), 1062.CrossRefGoogle Scholar
  15. Douglas, H. (2014). Pure science and the problem of progress. Studies in History and Philosophy of Science Part A,46, 55–63.CrossRefGoogle Scholar
  16. Douglas, H. (2018). From tapestry to loom: Broadening the perspective on values in science. Philosophy, Theory, and Practice in Biology.  https://doi.org/10.3998/ptpbio.16039257.0010.008.CrossRefGoogle Scholar
  17. Dutton, D. B. (1992). Worse than the disease: Pitfalls of medical progress. Cambridge: Cambridge University Press.Google Scholar
  18. Elliott, K. C. (2017). A tapestry of values: An introduction to values in science. Oxford: Oxford University Press.CrossRefGoogle Scholar
  19. Elliott, K. C., McCright, A. M., Allen, S., & Dietz, T. (2017). Values in environmental research: Citizens’ views of scientists who acknowledge values. PLoS ONE,12(10), e0186049.CrossRefGoogle Scholar
  20. Ferguson, J. H. (1953). Effect of stilbestrol on pregnancy compared to the effect of a placebo. American Journal of Obstetrics and Gynecology,65(3), 592–601.CrossRefGoogle Scholar
  21. Fricker, M. (1998). Rational authority and social power: Towards a truly social epistemology. Proceedings of the Aristotelian Society,98, 159–177.CrossRefGoogle Scholar
  22. Fricker, M. (2007). Epistemic injustice: Power and the ethics of knowing. Oxford: Oxford University Press.CrossRefGoogle Scholar
  23. Fricker, M. (2010). Replies to Alcoff, Goldberg, and Hookway on epistemic injustice. Episteme,7, 164–178.CrossRefGoogle Scholar
  24. Fugh-Berman, A., & Ahari, S. (2007). Following the script: How drug reps make friends and influence doctors. PLoS Medicine,4(4), e150.CrossRefGoogle Scholar
  25. Gaffin, Ben, and Associates, American Medical Association, & Pharmaceutical Manufacturers Association. (1958). Attitudes of US physicians toward the American Pharmaceutical Industry. The Author.Google Scholar
  26. Gillam, R., & Bernstein, B. J. (1987). Doing harm: The DES tragedy and modern American medicine. The Public Historian,9, 57–82.CrossRefGoogle Scholar
  27. Greene, J. A. (2004). Attention to ‘details’: Etiquette and the pharmaceutical salesman in postwar American. Social Studies of Science,34(2), 271–292.CrossRefGoogle Scholar
  28. Greenhill, J. (1949). The 1949 yearbook of obstetrics and gynecology. Chicago: Yearbook Publishers.Google Scholar
  29. Hearings Before Senate Subcommittee on Antitrust and Monopoly. (1961). Washington, DC: US Government Printing.Google Scholar
  30. Heinonen, O. P. (1973). Diethylstilbestrol in pregnancy. Frequency of exposure and usage patterns. Cancer,31(3), 573–577.CrossRefGoogle Scholar
  31. Holman, B., & Bruner, J. (2015). The problem of intransigently biased agents. Philosophy of Science,82, 956–968.CrossRefGoogle Scholar
  32. Holman, B. (unpublished). Medical knowledge as what doctors know.Google Scholar
  33. Hume, D (1739/2000). An enquiry concerning human understanding. Oxford: Oxford University Press.Google Scholar
  34. IARC. International Agency for Research on Cancer. (2012). Diethylstilbestrol. A review of human carcinogens. IARC Monograph Evaluation Carcinogenic Risks for Humans,100, 175–218.Google Scholar
  35. JAMA (1949). JAMA, 139, 130.Google Scholar
  36. John, S. (2015). Inductive risk and the contexts of communication. Synthese,192(1), 79–96.CrossRefGoogle Scholar
  37. John, S. (2018a). Epistemic trust and the ethics of science communication: Against transparency, openness, sincerity and honesty. Social Epistemology,32(2), 75–87.CrossRefGoogle Scholar
  38. John, S. (2018b). Science, truth and dictatorship: Wishful thinking or wishful speaking? Studies in History and Philosophy of Science. https://doi.org/10.1016/j.shpsa.2018.12.003.
  39. John, S. (2018c). Scientific deceit. Synthese. https://doi.org/10.1007/s11229-018-02017-4.
  40. Kaufman, R. H. (1982). Structural changes of the genital tract associated with in utero exposure to diethylstilbestrol. Obstetrics and Gynecology Annual,11, 187.Google Scholar
  41. Kaufman, R. H., Adam, E., Hatch, E. E., Noller, K., Herbst, A. L., Palmer, J. R., et al. (2000). Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring. Obstetrics and Gynecology,96(4), 483–489.Google Scholar
  42. Langston, N. (2010). Toxic bodies. New Haven: Yale University Press.Google Scholar
  43. Lasagna, L. (1955). Statistics, sophistication, and sacred cows. Clinical Research Proceedings,3, 185.Google Scholar
  44. Lexchin, J. (1984). The real pushers: A critical analysis of the Canadian drug industry. Vancouver: New Star Books.Google Scholar
  45. McGarity, T., & Wagner, W. (2008). Bending science: How special interests corrupt public health research. Cambridge, MA: Harvard University Press.Google Scholar
  46. Medina, J. (2011). The relevance of credibility excess in a proportional view of epistemic injustice: Differential epistemic authority and the social imaginary. Social Epistemology,25(1), 15–35.CrossRefGoogle Scholar
  47. Merrick, T. (2017). From ‘Intersex’to ‘DSD’: A case of epistemic injustice. Synthese.  https://doi.org/10.1007/s11229-017-1327-x.CrossRefGoogle Scholar
  48. Meyers, R. (1983). DES: The bitter pill. New York: Seaview/Putnam.Google Scholar
  49. Oldani, M. (2002). Tales from the “Script”: An insider/outside view of pharmaceutical sales practice. Kroeber Anthropological Society Papers,92–93, 147–176.Google Scholar
  50. Oldani, M. (2004). Thick prescriptions: Toward an interpretation of pharmaceutical sales practices. Medical Anthropology Quarterly,18, 325–356.CrossRefGoogle Scholar
  51. Podolsky, S. H. (2015). The antibiotic era: Reform, resistance, and the pursuit of a rational therapeutics. Baltimore: JHU Press.Google Scholar
  52. Reed, C. E., & Fenton, S. E. (2013). Exposure to diethylstilbestrol during sensitive life stages: A legacy of heritable health effects. Birth Defects Research Part C: Embryo Today: Reviews,99(2), 134–146.CrossRefGoogle Scholar
  53. Reid, D. D. (1955). The use of hormones in the management of pregnancy in diabetics. Lancet,2, 833–836.Google Scholar
  54. Robinson, D., & Shettles, L. B. (1952). The use of diethylstilbestrol in threatened abortion. American Journal of Obstetrics and Gynecology,63(6), 1330–1333.CrossRefGoogle Scholar
  55. Rosenstock, S., O’Connor, C., & Bruner, J. (2017). In epistemic networks, is less really more? Philosophy of Science,84, 234–252.CrossRefGoogle Scholar
  56. Sah, S., & Fugh-Berman, A. (2013). Physicians under the influence: Social psychology and industry marketing strategies. The Journal of Law, Medicine & Ethics,41(3), 665–672.CrossRefGoogle Scholar
  57. Smith, O. (1948). Diethylstilbestrol in the prevention and treatment of complications of pregnancy. American Journal of Obstetrics and Gynecology,56(5), 821–834.CrossRefGoogle Scholar
  58. Smith, O. W., & Smith, G. V. S. (1949). The influence of diethylstilbestrol on the progress and outcome of pregnancy as based on a comparison of treated with untreated primigravidas. American Journal of Obstetrics and Gynecology,58(5), 994–1009.CrossRefGoogle Scholar
  59. Swyer, G. I. M., & Law, R. G. (1954). An evaluation of the ante-natal use of stilboestrol-preliminary report. Journal of Endocrinology,10, vi–vii.Google Scholar
  60. Troisi, R., Hatch, E. E., Titus-Ernstoff, L., Hyer, M., Palmer, J. R., Robboy, S. J., et al. (2007). Cancer risk in women prenatally exposed to diethylstilbestrol. International Journal of Cancer,121(2), 356–360.CrossRefGoogle Scholar
  61. Warner, J. H. (2014). The therapeutic perspective: Medical practice, knowledge, and identity in America, 1820–1885. Princeton NJ: Princeton University Press.Google Scholar
  62. Wilholt, T. (2009). Bias and values in scientific research. Studies in History and Philosophy of Science Part A, 40(1), 92–101.CrossRefGoogle Scholar
  63. Zollman, K. (2007). The communication structure of epistemic communities. Philosophy of Science,74, 574–587.CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Underwood International CollegeYonsei UniversitySeoulSouth Korea
  2. 2.Faculty of HumanitiesUniversity of JohannesburgJohannesburgSouth Africa

Personalised recommendations